Transaction #37243 · Form 4 · 0002111813-26-000013
Faeth Therapeutics, Inc. · Gift received · Common Stock
Faeth Therapeutics, Inc. · Transacted October 30, 2026 · Filed November 3, 2026
What does this filing report?
An SEC Form 4 filing for Faeth Therapeutics, Inc. records a gift received involving Common Stock on October 30, 2026. The reported quantity was 100,000. The filing date is November 3, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Faeth Therapeutics, Inc.
- Company CIK
- 0001829802
- Security type
- Non-derivative
- Acquisition type
- Gift received · Code G
- Quantity acquired
- 100,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 100,000
- Ownership description
- See footnote
- SEC acceptance time
- Nov 3, 2026, 8:33 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Parikh Anand Kiran ↗
President and CEO · Director
CIK 0002111813
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents the number of the shares of the Issuer's Common Stock gifted to AKP Irrevocable Trust for the benefit of the Reporting Person's immediate family members.
- F2
- The shares are held of record by the AKP Irrevocable Trust, of which the Reporting Person's immediate family members are the beneficiaries. Preservation Trust Company serves as trustee, and the Reporting Person serves as investment advisor with authority to direct the trustee on the investment of trust assets. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.